The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal

Citation:

Chen WY, Zhang H, Gatta E, Glover EJ, Pandey SC, and Lasek AW. “The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal.” Alcohol, 78, Pp. 79-87. Publisher’s Version